Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Intertrochanteric Hip Fractures
NCT01940536Phase 4Withdrawn
- Sponsor
- Hospital for Special Surgery
- Start
- Dec 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in intertrochanteric hip fracture, hemorrhage, sponsored by Hospital for Special Surgery. Planned start Dec 2015; status: withdrawn.
02
Drugs
tranexamic acid
03
Conditions
intertrochanteric hip fracturehemorrhage
Beyond the preview
Go deeper on NCT01940536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01940536.